Featured Research

from universities, journals, and other organizations

New Approach To Attacking Alzheimer's Disease Studied

Date:
May 6, 1999
Source:
American Chemical Society
Summary:
Researchers have developed an array of new chemicals that may attack Alzheimer's disease in a unique way. The compounds target a little understood enzyme called butyrylcholinesterase, which has recently been shown to be elevated in the brains of patients with AD.

Researchers have developed an array of new chemicals that may attack Alzheimer's disease in a unique way. The compounds target a little understood enzyme called butyrylcholinesterase, which has recently been shown to be elevated in the brains of patients with AD.

Details about the research will appear in the Journal of Medicinal Chemistry, published by the American Chemical Society (ACS), the world's largest scientific society. The paper became available on the ACS Web May 4 and will be in the journal's May 20 print edition.

Alzheimer's disease is the fourth leading cause of death in Western countries and is a cause of severe dementia in at least four million Americans. Those over 85 years of age, the fastest growing portion of the U.S. population, have a fifty-fifty chance of developing the disease.

One characteristic of Alzheimer's disease is decreased amounts of acetylcholine, a brain signaling chemical which plays a critical role in memory processing. After doing its job, acetylcholine is normally inactivated by enzymes called cholinesterases, which come in two forms and are found throughout the body. The first, acetylcholinesterase (AChE), works at nerve endings; current Alzheimer's disease drugs aim to temporarily disable it. The role of the other form, butyrylcholinesterase (BChE), is largely unknown. "Consequently, there has been minimal interest (among drug makers) in the design, synthesis and development of butyrylcholinesterase inhibitors," says the study's co-author Nigel H. Greig, Ph.D., from the National Institute on Aging's Intramural Research Program. The Institute's Qian-sheng Yu, Ph.D., is lead author on the paper.

While some current drugs randomly inhibit both AChE and BChE, Greig says those tend to have more side effects. He adds that "the present study represents the first to develop highly selective inhibitors of BChE alone with appropriate characteristics for use in animals and humans." Recent laboratory studies have shown that BChE levels are increased in the beta-amyloid plaques which form in the brains of patients with Alzheimer's disease and that BChE amplifies plaque toxicity.

"These facts suggest," write the researchers, "that inappropriate BChE activity increases the risk and/or progression of Alzheimer's disease." What else it does, however, is unclear. People with a genetic lack of BChE activity seem to get along just fine, so scientists hope that side effects will be minimal. In fact, Greig thinks "one can inhibit BChE completely and there will not be any toxic effects," even though he says their new inhibitors do not permanently disable the enzyme.

The authors, who include University of North Carolina scientists, say preliminary studies indicate that their BChE inhibitors improve cognition and learning in rodents. They have now teamed with the newly formed biopharmaceutical company Axonyx Incorporated in New York, New York. The researchers hope, within the next 18-24 months, to develop a lead compound that can be tested in patients with Alzheimer's disease.

###

A nonprofit organization with a membership of nearly 159,000 chemists and chemical engineers, the American Chemical Society publishes scientific journals and databases, convenes major research conferences, and provides educational, science policy and career programs in chemistry. Its main offices are in Washington, D.C., and Columbus, Ohio.


Story Source:

The above story is based on materials provided by American Chemical Society. Note: Materials may be edited for content and length.


Cite This Page:

American Chemical Society. "New Approach To Attacking Alzheimer's Disease Studied." ScienceDaily. ScienceDaily, 6 May 1999. <www.sciencedaily.com/releases/1999/05/990506070327.htm>.
American Chemical Society. (1999, May 6). New Approach To Attacking Alzheimer's Disease Studied. ScienceDaily. Retrieved July 30, 2014 from www.sciencedaily.com/releases/1999/05/990506070327.htm
American Chemical Society. "New Approach To Attacking Alzheimer's Disease Studied." ScienceDaily. www.sciencedaily.com/releases/1999/05/990506070327.htm (accessed July 30, 2014).

Share This




More Health & Medicine News

Wednesday, July 30, 2014

Featured Research

from universities, journals, and other organizations


Featured Videos

from AP, Reuters, AFP, and other news services

Health Insurers' Profits Slide

Health Insurers' Profits Slide

Reuters - Business Video Online (July 30, 2014) Obamacare-related costs were said to be behind the profit plunge at Wellpoint and Humana, but Wellpoint sees the new exchanges boosting its earnings for the full year. Fred Katayama reports. Video provided by Reuters
Powered by NewsLook.com
Concern Grows Over Worsening Ebola Crisis

Concern Grows Over Worsening Ebola Crisis

AFP (July 30, 2014) Pan-African airline ASKY has suspended all flights to and from the capitals of Liberia and Sierra Leone amid the worsening Ebola health crisis, which has so far caused 672 deaths in Guinea, Liberia and Sierra Leone. Duration: 00:43 Video provided by AFP
Powered by NewsLook.com
At Least 20 Chikungunya Cases in New Jersey

At Least 20 Chikungunya Cases in New Jersey

AP (July 30, 2014) At least 20 New Jersey residents have tested positive for chikungunya, a mosquito-borne virus that has spread through the Caribbean. (July 30) Video provided by AP
Powered by NewsLook.com
Generics Eat Into Pfizer's Sales

Generics Eat Into Pfizer's Sales

Reuters - Business Video Online (July 29, 2014) Pfizer, the world's largest drug maker, cut full-year revenue forecasts because generics could cut into sales of its anti-arthritis drug, Celebrex. Fred Katayama reports. Video provided by Reuters
Powered by NewsLook.com

Search ScienceDaily

Number of stories in archives: 140,361

Find with keyword(s):
Enter a keyword or phrase to search ScienceDaily for related topics and research stories.

Save/Print:
Share:

Breaking News:
from the past week

In Other News

... from NewsDaily.com

Science News

Health News

    Environment News

    Technology News



      Save/Print:
      Share:

      Free Subscriptions


      Get the latest science news with ScienceDaily's free email newsletters, updated daily and weekly. Or view hourly updated newsfeeds in your RSS reader:

      Get Social & Mobile


      Keep up to date with the latest news from ScienceDaily via social networks and mobile apps:

      Have Feedback?


      Tell us what you think of ScienceDaily -- we welcome both positive and negative comments. Have any problems using the site? Questions?
      Mobile: iPhone Android Web
      Follow: Facebook Twitter Google+
      Subscribe: RSS Feeds Email Newsletters
      Latest Headlines Health & Medicine Mind & Brain Space & Time Matter & Energy Computers & Math Plants & Animals Earth & Climate Fossils & Ruins